连续血糖监测设备市场规模、份额和成长分析（按组件、连接类型、最终用途和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，持续血糖监测市场规模将达到 98.4 亿美元，到 2025 年将达到 111.7 亿美元，到 2033 年将达到 307.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 13.5%。

糖尿病盛行率的不断攀升，以及持续血糖监测（CGM）设备的日益普及，推动了市场显着成长。糖尿病影响全球数百万人，CGM设备正成为糖尿病管理的重要工具，能够提供有关饮食习惯、药物依从性、运动量和整体健康状况的重要资讯。数位化治疗解决方案的开发正在加强製造商与患者之间的合作，促进更全面的糖尿病管理方法。目前，众多应用程式能够有效利用CGM数据来识别趋势并建议生活方式的改变。这些创新功能不仅有助于患者管理自身健康，也显着推动了CGM设备市场的成长，凸显了其在糖尿病照护中日益重要的角色。

持续血糖监测设备市场驱动因素

全球糖尿病盛行率的不断上升是推动有效监测和管理工具（例如持续血糖监测设备）需求的主要因素。随着越来越多的患者被诊断出患有这种慢性疾病，可靠、即时地追踪血糖值变得至关重要。这些设备能够帮助患者及时调整治疗方案，进而增强其健康管理能力，并有助于全面改善糖尿病管理。人们对更健康、更高品质生活的追求也进一步推动了市场成长，他们寻求创新的解决方案来维持最佳血糖值并预防糖尿病相关併发症。

限制连续血糖监测设备市场的因素

儘管连续血糖监测设备的准确性有所提高，但与传统血糖检测法相比，仍存在一些偏差。这种差异可能导致使用者对测量结果可靠性产生担忧，进而影响使用者对这项技术的信任度和接受度。因此，有些人更倾向于依赖传统方法，尤其是在紧急情况下，准确的血糖值对于健康管理至关重要。这种对全面接受连续血糖监测的犹豫态度可能会阻碍这些创新设备在市场上的广泛应用。

连续血糖监测设备市场趋势

持续血糖监测（CGM）设备市场正呈现与数位健康平台日益融合的明显趋势，显着提升了使用者体验和资料管理效率。这种融合使用户能够轻鬆监测血糖值及其他健康指标，从而实现更全面的个人健康管理。随着对科技主导健康解决方案的需求不断增长，CGM设备正发展成为提供即时数据分析的先进工具，帮助使用者积极调整生活方式，改善糖尿病管理。这一趋势反映了医疗保健系统向互联互通的更广泛转变，在这个系统中，数据协同效应使用户能够做出明智的健康决策，并获得更好的健康结果。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术进步
• 监管环境
• 客户和购买标准分析
• 专利分析

全球连续血糖监测设备市场规模（按组件划分）及复合年增长率（2026-2033 年）

• 发送器
• 感应器
• 接收器

全球连续血糖监测设备市场规模（按连接类型和复合年增长率划分）（2026-2033 年）

• Bluetooth
• 4G
• 其他的

全球连续血糖监测设备市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 医院
• 居家医疗

全球连续血糖监测设备市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories（USA）
• Dexcom, Inc.（USA）
• Medtronic PLC（Ireland）
• Roche（Switzerland）
• Senseonics Holdings, Inc.（USA）
• GlySens Incorporated（USA）
• Novo Nordisk A/S（Denmark）
• Insulet Corporation（USA）
• Tandem Diabetes Care, Inc.（USA）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Ypsomed AG（Switzerland）
• Menarini Diagnostics（Italy）
• Nemaura Medical Inc.（UK）
• Medisana GmbH（Germany）
• Sanofi（France）
• Johnson & Johnson（USA）
• Braun Melsungen AG（Germany）
• Arkray, Inc.（Japan）
• Terumo Corporation（Japan）
• MicroTech Medical（China）

结论与建议

Continuous Glucose Monitoring Devices Market size was valued at USD 9.84 Billion in 2024 and is poised to grow from USD 11.17 Billion in 2025 to USD 30.76 Billion by 2033, growing at a CAGR of 13.5% during the forecast period (2026-2033).

The rising prevalence of diabetes, coupled with the increasing adoption of continuous glucose monitoring (CGM) devices, is driving substantial market growth. With millions affected globally, CGM devices are becoming essential tools for managing diabetes, providing critical insights into dietary habits, medication adherence, physical activity, and overall health. The development of digital therapeutic solutions has enhanced connectivity between manufacturers and patients, fostering a more integrated approach to diabetes management. Numerous applications are now available, effectively leveraging CGM data to identify trends and advise on lifestyle modifications. These innovative features not only empower patients in their health journeys but also significantly contribute to the positive growth trajectory of the CGM device market, highlighting its expanding role in diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Glucose Monitoring Devices Market Segments Analysis

Global Continuous Glucose Monitoring Devices Market is segmented by Component, Connectivity, End-use and region. Based on Component, the market is segmented into Transmitters, Sensors and Receivers. Based on Connectivity, the market is segmented into Bluetooth, 4G and Others. Based on End-use, the market is segmented into Hospitals and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Continuous Glucose Monitoring Devices Market

The rising global incidence of diabetes serves as a major catalyst for the demand for effective monitoring and management tools, such as continuous glucose monitoring devices. As more individuals are diagnosed with this chronic condition, the need for reliable, real-time tracking of glucose levels has become paramount. These devices offer patients enhanced control over their health by allowing for timely adjustments to their treatment plans, thereby improving overall diabetes management. The emphasis on better health outcomes and quality of life further propels the growth of this market, as individuals seek innovative solutions to maintain optimal glucose levels and prevent complications associated with diabetes.

Restraints in the Continuous Glucose Monitoring Devices Market

Despite the advancements in accuracy of continuous glucose monitoring devices, there remain instances where these devices may show occasional inconsistencies when contrasted with conventional blood glucose testing methods. This variability can lead to apprehensions among users regarding the reliability of the readings, impacting their trust and overall acceptance of the technology. As a result, some individuals may prefer to rely on traditional methods, especially in critical situations where precise glucose levels are imperative for health management. This hesitation to fully embrace continuous monitoring could hinder the broader adoption of these innovative devices within the market.

Market Trends of the Continuous Glucose Monitoring Devices Market

The Continuous Glucose Monitoring (CGM) devices market is witnessing a robust trend towards integration with digital health platforms, enhancing user experience and data management. This convergence enables individuals to effortlessly monitor their glucose levels alongside additional health metrics, promoting a more holistic approach to personal health management. As demand for technology-driven health solutions rises, CGM devices are evolving into sophisticated tools that offer real-time data insights, facilitating proactive lifestyle adjustments and improved diabetes management. This trend reflects a broader shift towards interconnected healthcare systems, where data synergy supports users in making informed health decisions and achieving better health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Patent Analysis

Global Continuous Glucose Monitoring Devices Market Size by Component & CAGR (2026-2033)

• Market Overview
• Transmitters
• Sensors
• Receivers

Global Continuous Glucose Monitoring Devices Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Bluetooth
• 4G
• Others

Global Continuous Glucose Monitoring Devices Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare

Global Continuous Glucose Monitoring Devices Market Size & CAGR (2026-2033)

• North America (Component, Connectivity, End-use)
  • US
  • Canada
• Europe (Component, Connectivity, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Connectivity, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Connectivity, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Connectivity, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlySens Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisana GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations